Health Care & Life Sciences » Pharmaceuticals | Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD0.12
Market Cap
CAD36.06 M
Shares Outstanding
26.91 M
Public Float
16.42 M

Profile

Address
209 Oak Park Boulevard
Oakville Ontario L6H 0M2
Canada
Employees -
Website http://www.cipherpharma.com
Updated 07/08/2019
Cipher Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the robust and diversified portfolio of commercial and late-stage products. It also acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Its products include Actikerall, Aclaro, Beteflam, Epuris, Vaniqa, Dermadexin, Pruridexin, Ozenoxacin, Lipofen, Conzip, and Durela.

Financials

View All

Robert D. Tessarolo
President, Chief Executive Officer & Director
Arthur M. Deboeck
Director